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TO THE EDITOR: Gilbert and colleagues1
report thyroid function test results in a large
number of pregnant women in Western
Australia during the first trimester. While
assessment of thyroid status is increasingly
important in pregnancy, they do not present
a strong enough argument for their reference
ranges to be adopted. Their controls con-
sisted of only 100 blood donors, and it is
not clear whether these were age-matched
with patients. Differences between pregnant
and non-pregnant thyroid hormone ranges
were too small to justify use of separate
ranges. We assume from the article that the
controls were not screened for thyroid anti-
bodies. Prevalence of thyroid autoimmunity
is high in women of reproductive age,
whether or not they are pregnant.2
Serum thyrotropin (TSH) concentration is
reduced in up to 20% of women during
their first trimester, often with modestly
increased thyroid hormones. The thyroid-
stimulatory effect of human chorionic
gonadotropin may help ensure adequate
thyroxine delivery to the fetus. It is surely
more important for clinicians to understand
this than to have reference ranges that con-
ceal normal physiological changes.
Gilbert et al do not state whether patients
with multiple or assisted-conception preg-
nancies were included — both are more
likely to have abnormal thyroid test results.2
Their detection limit for TSH and the lower
limit of normal differed by only 0.01 mU/L
— they could therefore not reliably distin-
guish low TSH from suppressed TSH. They
screened only 61% of pregnant women in
WA. It is inconceivable that there was not a
selection bias, as current guidelines3 advo-
cate only screening high-risk groups such as
those with a history of thyroid disease or
previous poor obstetric outcome.
Ethnic differences in TSH levels have
been reported. However, data from the
United States National Health and Nutrition
Examination Survey (NHANES) suggest that
TSH levels in Hispanics are no different to
those of white people,4 contrary to what is
suggested by Gilbert et al.1 Increased mis-
carriage risk may relate to autoimmunity
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itself, rather than altered thyroid function.
The study by Negro et al5 is, to date, the
only one showing a decrease in miscarriages
when thyroxine is given to thyroid anti-
body-positive women. However, the TSH
level before thyroxine was given was com-
fortably within the normal range reported
by Gilbert et al.
Publications in this complex area are
only informative if they tell us something
about thyroid physiology or about diagno-
sis and management of thyroid disorders.
While laboratories must validate their ref-
erence ranges, it is unlikely that those
reported by Gilbert et al could be general-
ised to the ethnically diverse and geograph-
ically dispersed Australian population.
Also, as described,1 patients would have to
be screened routinely for thyroid antibod-
ies to ensure that the quoted ranges were
applicable.
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